<DOC>
	<DOCNO>NCT00240032</DOCNO>
	<brief_summary>This study design compare injection skin ( injection site ) reaction antihistamine ( Zyrtec® ) placebo take prior perform daily Copaxone® injection . Patients assign ( like flip coin ) take either placebo antihistamine ( Zyrtec® ) prior perform daily Copaxone® injection . The patient physician unaware whether take placebo antihistamine study .</brief_summary>
	<brief_title>A Study Evaluate Impact Skin ( Injection Site ) Reactions Taking Antihistamine ( Zyrtec® ) Placebo Prior Daily Injections Copaxone® .</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<mesh_term>Histamine Antagonists</mesh_term>
	<mesh_term>Histamine H1 Antagonists</mesh_term>
	<mesh_term>Glatiramer Acetate</mesh_term>
	<criteria>Male female 18 year age old Diagnosis RRMS Beginning recently ( within &lt; 3months ) begin selfinjecting Copaxone® Taking immunomodulatory therapy conjunction Copaxone® Unable perform subcutaneous selfinjection Pregnant try become pregnant , breast feeding study Previously participate study another clinical trial past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>